Zepbound 7.5MG/.5ML 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9LM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,894
Award facts
- Contract value 100% obligated
- $23,894.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,894.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Zepbound 7.5mg/0.5ml (4 packs), with completion targeted for January 27, 2026. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle extending through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Zepbound is a semaglutide-based weight management medication, reflecting the Defense Health Agency's medical supply needs for military personnel and beneficiaries. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent success in delivering specialized pharmaceuticals, including diabetes medications, neurological treatments, and other therapeutic products across multiple therapeutic domains to the Department of Defense and related federal healthcare systems. This delivery order represents one of numerous transactions under the prime indefinite delivery vehicle, showcasing the company's capability to fulfill federal procurement requirements for critical medical commodities on an ongoing basis.
Quick answers
Who was awarded contract SPE2DR26FW9LM?
SPE2DR26FW9LM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FW9LM worth?
The government has obligated $23,894 on SPE2DR26FW9LM.
Is contract SPE2DR26FW9LM an order under another contract?
Yes. SPE2DR26FW9LM is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9LM competed?
The extent of competition for SPE2DR26FW9LM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award